Viewing Study NCT05861050


Ignite Creation Date: 2025-12-24 @ 5:15 PM
Ignite Modification Date: 2025-12-25 @ 6:37 PM
Study NCT ID: NCT05861050
Status: RECRUITING
Last Update Posted: 2025-08-29
First Post: 2023-05-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma
Sponsor: City of Hope Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module